Proprietary AI analyst is now available

Dr.Finance Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dr.Finance and similar public comparables like Wierzyciel, Ditix, One Solution, Ventana Global and more.

Dr.Finance Overview

About Dr.Finance

Dr.Finance SA is a financial intermediary in the sale of loans and other financial products. It operates in the business of Working capital loans, Investment loans, Leasing, and Factoring.


Founded

2008

HQ

Poland

Employees

2

Financials (FY)

Revenue: $1M
EBITDA: ($76K)

EV

$1M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dr.Finance Financials

Dr.Finance reported last fiscal year revenue of $1M and negative EBITDA of ($76K).

In the same fiscal year, Dr.Finance generated $1M in gross profit, ($76K) in EBITDA losses, and had net loss of ($57K).


Dr.Finance P&L

In the most recent fiscal year, Dr.Finance reported revenue of $1M and EBITDA of ($76K).

Dr.Finance is unprofitable as of last fiscal year, with gross margin of 96%, EBITDA margin of (6%), and net margin of (5%).

See analyst estimates for Dr.Finance
Last FY202320242025202620272028
Revenue$1M$2M$3M$1M
Gross Profit$1M$2M$3M$1M
Gross Margin96%96%96%96%
EBITDA($76K)($11K)($51K)($76K)
EBITDA Margin(6%)(1%)(2%)(6%)
EBIT Margin(6%)(1%)(2%)(6%)
Net Profit($57K)($6K)($67K)($57K)
Net Margin(5%)(0%)(2%)(5%)

Financial data powered by Morningstar, Inc.

Dr.Finance Stock Performance

Dr.Finance has current market cap of $1M, and enterprise value of $1M.

Market Cap Evolution


Dr.Finance's stock price is $0.39.

Dr.Finance share price decreased by 10.6% in the last 30 days, and increased by 72.3% in the last year.

Dr.Finance has an EPS (earnings per share) of $-0.02.

See more trading valuation data for Dr.Finance
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1M$1M-6.4%-10.6%23.3%72.3%$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dr.Finance Valuation Multiples

Dr.Finance trades at 1.2x EV/Revenue multiple, and (19.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for Dr.Finance

Dr.Finance Financial Valuation Multiples

As of June 6, 2026, Dr.Finance has market cap of $1M and EV of $1M.

Dr.Finance has a P/E ratio of (25.6x).

Last FY202320242025202620272028
EV/Revenue1.2x0.8x0.5x1.2x
EV/EBITDA(19.0x)(126.6x)(28.5x)(19.0x)
EV/EBIT(19.0x)(114.4x)(28.2x)(19.0x)
EV/Gross Profit1.2x0.9x0.5x1.2x
P/E(25.6x)(227.3x)(21.9x)(25.6x)
EV/FCF(20.8x)(28.1x)60.0x(20.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dr.Finance Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dr.Finance Margins & Growth Rates

In the most recent fiscal year, Dr.Finance reported gross margin of 96%, EBITDA margin of (6%), and net margin of (5%).

See estimated margins and future growth rates for Dr.Finance

Dr.Finance Margins

Last FY20242025202720282029
Gross Margin96%96%96%
EBITDA Margin(6%)(2%)(6%)
EBIT Margin(6%)(2%)(6%)
Net Margin(5%)(2%)(5%)
FCF Margin(6%)1%(6%)

Dr.Finance Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth65%(56%)
Gross Profit Growth65%(56%)
EBITDA Growth344%50%
EBIT Growth305%49%
Net Profit Growth936%(14%)
FCF Growth(147%)(389%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Dr.Finance Operational KPIs

Dr.Finance's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.6M for the same period.

Access forward-looking KPIs for Dr.Finance
Last FY202320242025202620272028
Revenue per Employee$0.6M---
Opex per Employee$0.6M---
Opex to Revenue102%97%98%102%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dr.Finance Competitors

Dr.Finance competitors include Wierzyciel, Ditix, One Solution, Ventana Global, LexBono, Akcept Finance, Femion Technology, Atlantis, Marka and PBS Finanse.

Most Dr.Finance public comparables operate across Specialty Finance.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Wierzyciel1.3x-(42.8x)-
Ditix16.3x-102.0x-
One Solution1.7x-19.7x-
Ventana Global----
LexBono3.2x-160.5x-
Akcept Finance72.9x-(16.2x)-
Femion Technology(1.5x)-43.7x-
Atlantis5.5x-5.9x-

This data is available for Pro users. Sign up to see all Dr.Finance competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dr.Finance

When was Dr.Finance founded?Dr.Finance was founded in 2008.
Where is Dr.Finance headquartered?Dr.Finance is headquartered in Poland.
How many employees does Dr.Finance have?As of today, Dr.Finance has over 2 employees.
Is Dr.Finance publicly listed?Yes, Dr.Finance is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Dr.Finance?Dr.Finance trades under DRF ticker.
When did Dr.Finance go public?Dr.Finance went public in 2008.
Who are competitors of Dr.Finance?Dr.Finance main competitors include Wierzyciel, Ditix, One Solution, Ventana Global, LexBono, Akcept Finance, Femion Technology, Atlantis, Marka, PBS Finanse.
What is the current market cap of Dr.Finance?Dr.Finance's current market cap is $1M.
What is the current revenue of Dr.Finance?Dr.Finance's last fiscal year revenue is $1M.
What is the current EV/Revenue multiple of Dr.Finance?Current revenue multiple of Dr.Finance is 1.2x.
Is Dr.Finance profitable?No, Dr.Finance is not profitable.
How many companies Dr.Finance has acquired to date?Dr.Finance hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Dr.Finance has invested to date?Dr.Finance hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Dr.Finance

Lists including Dr.Finance

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial